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Surgery for Esophageal Adenocarcinoma: Three field open McKeown
procedurehas a role in assessment and treatment of extensive locally
advanced esophageal adenocarcinoma with a favorable clinical and
pathological outcome
Mark H. Cooper, MD1, Paul Bown, MD1, Toni O. Pacioles, MD1

ABSTRACT
Esophageal adenocarcinoma has seen increased incidence due to gastroesophageal
reflux disease, smoking, and obesity. There are no established guidelines for screening
of esophageal cancer and many patients present late in their disease process.
Most early stage adenocarcinoma of the esophagus is treated with neoadjuvant
chemotherapy and radiation, followed by surgical resection. We describe a case of
locally advanced esophageal cancer where the patient had a relatively insignificant
response to neoadjuvant chemotherapy and radiation, who was then treated by
open direct resection of the esophagus and proximal stomach (three field McKeown
approach) with lymphadenectomy. There were no surgical complications such as
anstomotic leak or chylothorax. Pathology showed T2N0 disease.
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The mainstay of esophageal resection continues to be minimally invasive procedures
for early stage esophageal malignancy; however, locally advanced esophageal cancer
in the mediastinum occasionally requires an open direct approach. We felt that this was
a necessary procedure due to the large mass effect of the tumor, and a preoperative
staging of T2N3. In this case, despite recent advancements, there was a limited
response of the cancer to neoinduction therapy. Surgery was necessary to both assess
and treat this cancer, proving that older, established therapy is still relevant.
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INTRODUCTION

chest, combined with a left neck anastomosis.

Esophageal cancer treatment has been standardized
in recent years. Usual practice is now neoadjuvant
chemotherapy and radiation followed by surgery
in suitable patients.1 The initial operation for
esophageal cancer resection was an Ivor Lewis
procedure (laparotomy and right thoracotomy). More
recently, transhiatal esophagectomy (laparotomy and
left neck dissection) was described by Orringer at
the University of Michigan. The three field Mckeown
procedure is a combination of these two procedures
utilizing a right thoracotomy, laparotomy, and left
neck dissection. This allows the dissection to be
completed under direct visualization in the right

We describe a case of esophageal adenocarcinoma
that involved a significant length of the esophagus.
After chemotherapy and radiation, with restaging
by PET scan, the patient underwent a three field
esophagectomy and lymph node dissection. This
allowed dissection of the significant mass effect with
possible locally advanced disease to be done under
direct visualization and allowed an esophagogastric
anastomosis in the neck.
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CASE REPORT
A 64 year old white male was referred to our
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institution with esophageal adenocarcinoma. He had
a history of heavy alcohol and tobacco use as well as
gastroesophageal reflux, and was hepatitis A, B and C
positive. He had undergone a exploratory laparotomy
in the past for blunt trauma, and had symptoms of
dysphagia and weight loss. He was evaluated by
endoscopy and endoscopic ultrasound; that showed
a T2N3 tumor. PET scan showed a localized tumor
in the mediastinum with significant mass effect and
questionable invasion into the surrounding tissues.
Treatment comprised of initial laparotomy and
feeding jejunostomy placement for tube feeds,
followed by concurrent neoadjuvant chemoradiation.
The patient received 50Gy in 23 fractions, carboplatin
AUC 2, and paclitaxel 50 mg/m2 chemotherapy
over five weeks (Figure 1). A repeat PET scan
showed little regression of the tumor and sustained
significant mass effect in the distal esophagus that

extended proximally. There was no nodal spread or
distant metastatic disease. Endoscopy showed no
intraluminal disease and proximal gastric biopsies
were negative for cancer.
Coronal images of preoperative PET-CT scan
on patient with esophageal cancer. Patient had
been treated with concurrent neoadjuvant
chemoradiation. Patient received 50Gy in 23
fractions and also carboplatin AUC and paclitaxel for
a five week period. Patient scheduled for three field
esophagectomy.
The patient underwent bronchoscopy and right
thoracotomy with complete mobilization of the
intrathoracic esophagus, mediastinal lymph node
dissection, and ligation of the thoracic duct. Chest
tubes were placed and laparotomy was performed
with lysis of adhesions and gastric mobilization
on the right gastroepiploic artery, and a
duodenal kocher maneuver. A left neck
dissection was carried out to identifiy the
esophagus in the neck. The stomach was
transected in the abdomen and the distal
remnant was clearly able to reach to the
neck. The proximal stomach and esophagus
were pulled up from the neck with the new
gastric conduit following close behind. In
the neck, the esophagus was trensected and
the specimen of esophagus and proximal
stomach removed. Frozen sections of
the specimen showed clear margins. The
distal gastric conduit was anastomosed to
the proximal esophagus using a stapling
technique. A nasogastric tube was placed
throught the esophagogastric anastomosis
prior to its completion. The patient was
extubated in the operating room and went to
the recovery room in stable condition.
He required intubation on the fourth
postoperative day for mucous plugging;
bronchoscopy was required. After extubation
he underwent a swallow study that showed
no anastomotic leak. He was commenced
on clear liquids but required reintubation
for presumed aspiration and pseudomonas
pneumonia for which antibiotics were started.

FIGURE 1
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FIGURE 2
Bronchoscopy cleared his airway, and he was
extubated. His drains and chest tubes were removed
and he was moved to the ICU. ENT examination
of his vocal cords showed normal movement.
Due to issues with secretion management and
pneumonia, a bedside percutaneous tracheostomy
was performed. He was finally started on a clear
liquid diet and transferred to an acute skilled nursing
facility. Final pathology showed T2N0 disease with
clear margins and excised nodes negative (Figure 2).
Histopathology of the resected specimen.
Hematoxylin and eosin stain shows invasive
adenocarcinoma in the muscularis propria of the
esophageal wall. Final Pathology was a stage
T2N0M0. Preoperative studies showed a bulky
mediastinal mass and a T2N3M0 staging.
DISCUSSION
Data supporting the treatment of esophageal
cancer in patients deemed to be surgically operable
is documented in clinical trials. Results from the
CROSS trial have shown that induction neoadjuvant
chemoradiation treatment followed by surgery show
improved outcomes compared to surgical treatment
alone.1 There is a 29% complete response in patients
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undergoing chemoradiation
followed by surgery. Median
survival in the chemoradiation
surgery group was 49 months
versus 24 months in the surgery
group. For patients who do not
have a positive response to initial
chemoradiation treatment, such as
our patient, the choice of operation
becomes more significant. Based
on these data and PET scan
results, we considered the direct
operative assessment under direct
visualization to be important in this
overall surgical process. The patient
underwent a right thoracotomy and
direct mobilization of the tumor
from the mediastinum, and lymph
node dissection. We completed the
operation with a neck anastomosis,
allowing access to the esophagogastric anastomosis
should potential complications arise.
With improvements in robotic technology,
esophagectomy is now performed in fewer centers,
and a similar oncologic operation is performed in a
fashion providing less morbidity, less overall pain,
and quicker recovery for the patients. Minimally
invasive techniques range from the Ivor lewis
procedure to transhiatal esophagectomy; however,
open procedures may occasionally be necessary
to provide an alternative approach. In the present
study, the patient had mediastinal disease that was
marginally responsive to induction chemoradiation
therapy. An assessment of the tumor location and
invasiveness into surrounding mediastinal tissue
by direct palpation and dissection under direct
visualization was required in order to establish
resectability with good surgical margins, safe
dissection from surrounding mediastinal tissues,
and removal of all tumor and associated lymph
node stations. The final pathological diagnosis
in our patient was adenocarcinoma and T2N0
disease. The clinical staging of the patient was T2N3
disease based on the PET scan and the endoscopic
ultrasound.
Esophagectomy encompasses a variety of
procedures and treatment algorithms and has
become prevalent in centers where there is
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significant infrastructure to accomodate the
complexity of the treatment regimen and operative
and post operative support. Marshall Health
continues to adapt to the challenges of the changing
landscape in the management of esophageal
malignancy.
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